Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low Event Numbers May Undermine the Stability of G8-Based Mortality Prediction in ERCP.

Geriatrics & gerontology international·2026
Same author

Creatinine-Based eGFR Overestimation in Muscle Loss May Confound the Kidney-Muscle Association.

Geriatrics & gerontology international·2026
Same author

A deep-sea rare bacterium exhibits extraordinary metabolic versatility.

Cell reports·2026
Same author

A Missed Opportunity: Levasseur's Framework Could Explain the Null Association Between Local Event Participation and Loneliness.

Geriatrics & gerontology international·2026
Same author

The Unresolved Heterogeneity in Ultrasound-Based Muscle Mass Assessment.

Geriatrics & gerontology international·2026
Same author

Methodological Concerns in the Construction and Validation of a Musculoskeletal Biological Age Index.

Geriatrics & gerontology international·2026

Related Experiment Video

Updated: Sep 19, 2025

Establishment of a Surgically-induced Model in Mice to Investigate the Protective Role of Progranulin in Osteoarthritis
07:58

Establishment of a Surgically-induced Model in Mice to Investigate the Protective Role of Progranulin in Osteoarthritis

Published on: February 25, 2014

28.8K

sPLA2-IIA modifies progranulin deficiency phenotypes in mouse models.

Cha Yang1,2, Huan Du1,2, Gwang Bin Lee3

  • 1Department of Molecular Biology and Genetics, 345 Weill Hall, Ithaca, NY, 14853, USA.

Molecular Neurodegeneration
|June 17, 2025
PubMed
Summary
This summary is machine-generated.

Progranulin (PGRN) deficiency causes frontotemporal lobar degeneration (FTLD). A novel pathway involving sPLA2-IIA was identified, offering a better mouse model for FTLD-GRN research and potential therapeutic targets.

Keywords:
InflammationLysosomeMitochondriaMouse strain backgroundProgranulinsPLA2-IIA

More Related Videos

Assessing Social Dominance in Mouse Models Using the Tube Test
03:34

Assessing Social Dominance in Mouse Models Using the Tube Test

Published on: June 6, 2025

463
Modified Yeast-Two-Hybrid System to Identify Proteins Interacting with the Growth Factor Progranulin
07:56

Modified Yeast-Two-Hybrid System to Identify Proteins Interacting with the Growth Factor Progranulin

Published on: January 17, 2012

28.8K

Related Experiment Videos

Last Updated: Sep 19, 2025

Establishment of a Surgically-induced Model in Mice to Investigate the Protective Role of Progranulin in Osteoarthritis
07:58

Establishment of a Surgically-induced Model in Mice to Investigate the Protective Role of Progranulin in Osteoarthritis

Published on: February 25, 2014

28.8K
Assessing Social Dominance in Mouse Models Using the Tube Test
03:34

Assessing Social Dominance in Mouse Models Using the Tube Test

Published on: June 6, 2025

463
Modified Yeast-Two-Hybrid System to Identify Proteins Interacting with the Growth Factor Progranulin
07:56

Modified Yeast-Two-Hybrid System to Identify Proteins Interacting with the Growth Factor Progranulin

Published on: January 17, 2012

28.8K

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Progranulin (PGRN) haploinsufficiency is a primary genetic cause of frontotemporal lobar degeneration (FTLD).
  • Existing mouse models, particularly on the C57BL/6 background, exhibit mild PGRN deficiency phenotypes, limiting research into underlying pathways.
  • Understanding genetic background effects and regulatory pathways is crucial for developing effective FTLD models and therapies.

Purpose of the Study:

  • To investigate the impact of genetic background on progranulin deficiency phenotypes in mice.
  • To identify novel pathways that modulate PGRN deficiency-related phenotypes.
  • To establish a more robust mouse model for studying FTLD caused by PGRN mutations.

Main Methods:

  • Generated PGRN-deficient mice on both FVB/N and C57BL/6 backgrounds for comparative analysis.
  • Utilized immunostaining, western blot, RNA-sequencing, and proteomics to assess phenotypes and molecular changes.
  • Employed small molecule inhibitor treatment and adeno-associated virus (AAV)-mediated gene overexpression to explore pathway modulation.

Main Results:

  • PGRN deficiency in the FVB/N background led to more severe FTLD-related and lysosome-related phenotypes compared to C57BL/6.
  • Identified a novel interaction between PGRN and secreted phospholipase A2-IIA (sPLA2-IIA), which is upregulated in the FVB/N background.
  • sPLA2-IIA inhibition ameliorated PGRN deficiency phenotypes, while its overexpression exacerbated gliosis and lipofuscin accumulation.
  • Mitochondrial pathway dysregulation was observed in PGRN-deficient C57BL/6 mice but not in FVB/N mice.

Conclusions:

  • Established the FVB/N background as a superior model for studying FTLD-GRN due to enhanced phenotypic presentation.
  • Uncovered a novel pathway involving sPLA2-IIA that significantly modifies PGRN deficiency phenotypes.
  • These findings provide critical insights into FTLD pathogenesis and offer potential therapeutic targets.